These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6513245)

  • 1. Protection of mice against parenteral and oral infection with Yersinia enterocolitica.
    Nakajima R; Kaneko K; Hashimoto N
    Nihon Juigaku Zasshi; 1984 Oct; 46(5):721-7. PubMed ID: 6513245
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-resistance to fecal excretion of Yersinia enterocolitica in mice by oral vaccination of killed cells.
    Kaneko K; Hashimoto N
    Infect Immun; 1983 Jun; 40(3):1223-5. PubMed ID: 6852921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral vaccination with LcrV from Yersinia pestis KIM delivered by live attenuated Salmonella enterica serovar Typhimurium elicits a protective immune response against challenge with Yersinia pseudotuberculosis and Yersinia enterocolitica.
    Branger CG; Torres-Escobar A; Sun W; Perry R; Fetherston J; Roland KL; Curtiss R
    Vaccine; 2009 Aug; 27(39):5363-70. PubMed ID: 19596407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of protective immunity induced by Yersinia enterocolitica type-III secretion system mutants.
    Mamroud E; Flashner Y; Tidhar A; Ber R; Gur D; Aftalion M; Lazar S; Velan B; Shafferman A; Cohen S
    Adv Exp Med Biol; 2003; 529():425-30. PubMed ID: 12756803
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunity against Yersinia enterocolitica by vaccination with Yersinia HSP60 immunostimulating complexes or Yersinia HSP60 plus interleukin-12.
    Noll A; AutenriethIB
    Infect Immun; 1996 Aug; 64(8):2955-61. PubMed ID: 8757820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant bivalent fusion protein rVE confers active and passive protection against Yersinia enterocolitica infection in mice.
    Singh AK; Kingston JJ; Murali HS; Batra HV
    Vaccine; 2014 Mar; 32(11):1233-9. PubMed ID: 24486353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virulence, persistence, and immunogenicity of Yersinia enterocolitica O:8 aroA mutants.
    Bowe F; O'Gaora P; Maskell D; Cafferkey M; Dougan G
    Infect Immun; 1989 Oct; 57(10):3234-6. PubMed ID: 2777382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal immunization with Yersinia enterocolitica O:8 cellular extract protects against local challenge infection.
    Di Genaro MS; Escudero ME; Muñoz E; Aguilera C; Scardapane L; de Guzmán AM
    Microbiol Immunol; 1998; 42(11):781-8. PubMed ID: 9886151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yersinia enterocolitica ghost with msbB mutation provides protection and reduces proinflammatory cytokines in mice.
    Cai K; Zhang Y; Yang B; Chen S
    Vaccine; 2013 Jan; 31(2):334-40. PubMed ID: 23153438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria.
    Noll A; Bücheler N; Bohn E; Schirmbeck R; Reimann J; Autenrieth IB
    Eur J Immunol; 1999 Mar; 29(3):986-96. PubMed ID: 10092103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of oral and parenteral immunization with killed vaccines on the fecal shedding of mice fed Yersinia enterocolitica.
    Uchida I; Kaneko K; Hashimoto N
    Nihon Juigaku Zasshi; 1982 Jun; 44(3):539-42. PubMed ID: 6215520
    [No Abstract]   [Full Text] [Related]  

  • 12. Yersinia enterocolitica Yop mutants as oral live carrier vaccines.
    Leibiger R; Niedung K; Geginat G; Heesemann J; Trülzsch K
    Vaccine; 2008 Dec; 26(51):6664-70. PubMed ID: 18822332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against the lethal effect and arthritogenic capacity of Yersinia enterocolitica serovar O:3 for mice.
    de los Toyos JR; Díaz R; Hardisson C
    FEMS Microbiol Immunol; 1991 Oct; 3(5):289-97. PubMed ID: 1797050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA response by oral infection with an attenuated Yersinia enterocolitica mutant: implications for its use as oral carrier vaccine.
    Blanco HM; Lacoste MG; Eliçabe RJ; Di Genaro MS
    Vaccine; 2008 Dec; 26(51):6497-502. PubMed ID: 18835575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new quantitative method for oral vaccination of killed cells and persistence of the vaccination against fecal excretion of Yersinia enterocolitica.
    Yanagisawa J; Kaneko K; Hayashidani H; Ogawa M
    Nihon Juigaku Zasshi; 1987 Oct; 49(5):795-9. PubMed ID: 3682519
    [No Abstract]   [Full Text] [Related]  

  • 16. Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocolitica.
    Igwe EI; Rüssmann H; Roggenkamp A; Noll A; Autenrieth IB; Heesemann J
    Infect Immun; 1999 Oct; 67(10):5500-7. PubMed ID: 10496939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal immunoglobulin A (IgA) antibodies to Yersinia enterocolitica in mice orally vaccinated and infected.
    Shimono K; Kaneko K; Hayashidani H; Ogawa M
    Nihon Juigaku Zasshi; 1989 Apr; 51(2):273-7. PubMed ID: 2739202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
    Bohn E; Autenrieth IB
    J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral infection by Y. enterocolitica 0:8. Studies of immunization in a murine model].
    Frades MC; Díaz R
    Enferm Infecc Microbiol Clin; 1991 Dec; 9(10):608-12. PubMed ID: 1822150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice.
    Vogel U; Autenrieth IB; Berner R; Heesemann J
    Microb Pathog; 1993 Jul; 15(1):23-36. PubMed ID: 8412625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.